City
Epaper

Ayush Ministry will clear stance on Patanjali's COVID-19 medicines after reviewing its report: Shripad Naik

By ANI | Updated: June 24, 2020 11:25 IST

MoS for the Union Ayush Ministry Shripad Naik on Wednesday said that his Ministry will clear its stance on pharmaceutical giant Patanjali's newly-launched ayurvedic drugs 'Coronil and Swasari' for the novel coronavirus after reviewing the report sent by it.

Open in App

MoS for the Union Ayush Ministry Shripad Naik on Wednesday said that his Ministry will clear its stance on pharmaceutical giant Patanjali's newly-launched ayurvedic drugs 'Coronil and Swasari' for the novel coronavirus after reviewing the report sent by it.

However, the Minister said that it is good that Baba Ramdev has given a new medicine to the country.

"It is a good thing that Baba Ramdev has given a new medicine to the country but as per rule, it has to come to AYUSH Ministry first. They even said that they have sent a report. We will look into it and permission will be given after seeing the report," Naik told .

The AYUSH Ministry had said on Tuesday that it has taken cognizance of news in the media about Ayurvedic medicines developed for the treatment of COVID-19 by Patanjali Ayurved Ltd, Haridwar and said the company has been asked to "stop advertising/publicising such claims till the issue is duly examined".

In a release, the Ministry said that facts of the claim and details of the stated scientific study are not known to it.It had said the concerned Ayurvedic drug manufacturing company has been informed that such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and directives issued by the Central government in the wake of COVID outbreak.The Ministry had also issued a notification in April stating the requirements and the manner in which the research studies on COVID-19 with AYUSH interventions/medicines should be undertaken.The release had said that Patanjali Ayurved has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment, places where the research study was conducted for COVID-19, protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results from data of the study and "stop advertising/publicising such claims till the issue is duly examined.The Ministry had also requested concerned state licensing authority of Uttrakhand to provide copies of license and product approval details of Ayurvedic medicines being claimed for the treatment of COVID-19.Patanjali Ayurved on Tuesday launched 'Coronil and Swasari' claiming it to be Ayurvedic cure for treating COVID-19 and said clinical trials have shown favourable results.

( With inputs from ANI )

Tags: MinistryBaba RamdevAyush Ministry
Open in App

Related Stories

InternationalBaba Ramdev Slams US President Donald Trump’s Trade Policies, Calls It “Economic Terrorism" (Watch Video)

NationalPatanjali Misleading Advertisements Case: Supreme Court Closes Contempt Proceedings Against Ramdev

NationalIndia Must Stand With Its Minority Hindu Brothers, Says Baba Ramdev on Safety of Hindus in Bangladesh

NationalPatanjali Halts Sale of 14 Products After Licensing Suspension: Ramdev’s Company Informs Supreme Court

NationalPatanjali Misleading Ads Case: Supreme Court Adjourns Verdict on Contempt Notice Against Baba Ramdev and Others

National Realted Stories

National15th Rozgar Mela: New recruits across country celebrate receiving job letters from PM Modi

NationalHaryana CM Nayab Singh Saini Announces Rs 50 Lakh Compensation, Job for Family Member of Navy Officer Killed in Pahalgam Terror Attack

NationalBengal: NIA talks to widow & daughter of Pahalgam victim for over four hours

NationalDelhi CM Rekha Gupta orders construction of 500 new creches

NationalMillions benefited from Ayushman health cards, now is the time for Delhi: Hardeep Puri